Lumedx Corp. announced at the end of November that two Marshall Medical Centers hospitals have gone live with the first phase of a cardiovascular information system (CVIS) deployment. The two hospitals now using Lumedx CVIS software are Marshall Medical North in Guntersville, Ala.; and Marshall Medical South in Boaz, Ala.
Arterys has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Arterys Cardio DL application. Arterys Cardio DL is the first technology to be cleared by the FDA that leverages cloud computing and deep learning in a clinical setting.
January 9, 2017 β The U.S. Food and Drug Administration (FDA) issued a safety communication today concerning patient ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
January 6, 2017 β SentreHeart Inc. announced that it has completed the Stage I enrollment milestone in the aMAZE Trial ...
ITN and DAIC Editor Dave Fornell takes a tour of some of the most innovative new technologies being displayed on the ...
The RECHORD trial allows cardiovascular surgeons to replace damaged string-like tendons, called chordae, through a small incision while the heart is beating. The trial compares outcomes from this minimally invasive procedure to traditional open-heart mitral valve surgery, which requires the chest to be cracked. Specialized imaging is used to place the artificial chordae. PinnacleHealth is one of only 20 sites in the nation and the only hospital in Pennsylvania selected to participate in the trial. Up to 450 patients will be enrolled into the randomized trial.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Toshiba Medical announced in November that its Vantage Titan 1.5T/cS Edition magnetic resonance imaging (MRI) system with M-Power V3.6 software received U.S. Food and Drug Administration (FDA) clearance at the 2016 annual meeting of the Radiological Society of North America (RSNA). The new system retains all the patient-friendly features of the Vantage Titan 1.5T MR with added technology to simplify complex cardiac exams.
January 5, 2017 β Whether patients with mechanical heart valves and stents must take blood thinners depends on how ...
Too little sleep takes a toll on your heart, according to a new study presented at the 2016 annual meeting of the Radiological Society of North America (RSNA), Nov. 27-Dec. 1 in Chicago.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
January 5, 2017 β A new report published by Allied Market Research forecasts that the global thrombectomy devices market ...
The American Society of Echocardiography (ASE) is in the midst of Echovation Challenge 2017, a competition for its members, and the medical and scientific community at large, to develop innovative solutions in cardiovascular ultrasound technology.
January 5, 2017 β Reacting to a critical shortage of electrophysiology (EP) lab technicians and nurses who treat heart ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
At RSNA 2016, Siemens Healthineers unveiled its groundbreaking Compressed Sensing technology, which overcomes a major ...
January 5, 2017 β Working in concert, the American Society of Nuclear Cardiology (ASNC), the Intersocietal Accreditation ...
January 5, 2017 β Abbott announced it completed the acquisition of St. Jude Medical Inc. The transaction provides Abbott ...